EDGAR Filing Documents for 0001193125-23-253136

Form 8-K - Current report:

SEC Accession No. 0001193125-23-253136

Filing Date

2023-10-10

Accepted

2023-10-10 08:28:29

Documents

Period of Report

2023-10-05

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d570930d8k.htm iXBRL	8-K	50590
2	EX-3.1	d570930dex31.htm	EX-3.1	8894
3	EX-10.1	d570930dex101.htm	EX-10.1	109912
	Complete submission text file	0001193125-23-253136.txt		325923

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	spro-20231005.xsd	EX-101.SCH	2879
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	spro-20231005_lab.xml	EX-101.LAB	18741
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	spro-20231005_pre.xml	EX-101.PRE	11727
8	EXTRACTED XBRL INSTANCE DOCUMENT	d570930d8k_htm.xml	XML	3557

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139

Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600

Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)